Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2633521000168118 | Canakinumab (Novartis) (canakinumab 150 mg / 1 mL) injection, 1 x 1 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2633531000168115 | Canakinumab (Novartis) 150 mg/mL injection, 1 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Canakinumab (Novartis) 150 mg/mL injection, 1 mL vial | Is a | canakinumab 150 mg/mL injection, 1 mL vial | true | Inferred relationship | Some | ||
| Canakinumab (Novartis) 150 mg/mL injection, 1 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Canakinumab (Novartis) 150 mg/mL injection, 1 mL vial | has TPUU | Canakinumab (Novartis) (canakinumab 150 mg / 1 mL) injection, 1 mL vial (trade product unit of use) | true | Inferred relationship | Some | 1 | |
| Canakinumab (Novartis) 150 mg/mL injection, 1 mL vial | has TP | Canakinumab (Novartis) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Canakinumab (Novartis) (canakinumab 150 mg / 1 mL) injection, 1 x 1 mL vial (containered trade product pack) | Is a | True | Canakinumab (Novartis) 150 mg/mL injection, 1 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR